Download Diagnostico y Tratamiento ICC Sochicar

Guías para el diagnóstico y tratamiento de la Insuficiencia Cardíaca
secondary mitral regurgitation in end-stage cardiomyopathy
with mitral annuloplasty. Am J Cardiol 1996;78:966-9.
31. CONNOLLY HM, OH JK, ORSZULAK TA, et al. Aortic valve
replacement for aortic stenosis with severe left ventricular
dysfunction: prognostic indicators. Circulation 1997;95:2395-400.
32. BOLLING SF, PAGANI FD, DEEB GM, BACH DS. Intermediateterm outcome of mitral reconstruction in cardiomyopathy.
J Thorac Cardiovasc Surg 1998;115:381-6.
33. EVANGELISTA A, TORNOS P, SAMBOLA A, PERMANYERMIRALDA G, SOLER-SOLER J. Long-term vasodilator
therapy in patients with severe aortic regurgitation. N Engl
J Med 2005;353:1342–9
Tratamiento Pacientes en Estadio C.
1. GOOD CB, MCDERMOTT L, MCCLOSKEY B. Diet and serum
potassium in patients on ACE-inhibitors. JAMA 1995;274:538.
2. Working Group on Cardiac Rehabilitation and Exercise
Physiology and Working group on Heart Failure of the
European Society of Cardiology. Recommendations for exercise
testing in CHF patients. Eur Heart J 2001;22:37–45.
3. The SOLVD Investigators. Effect of enalapril on survival in
patients with reduced left ventricular ejection fractions and
congestive heart failure. N Engl J Med 1991;325:293-302.
4. COHN JN, JOHNSON G, ZIESCHE S, et al. A comparison
of enalapril with hydralazine-isosorbide dinitrate in the
treatment of chronic congestive heart failure. N Engl J Med
1991;325:303-10.
5. The CONSENSUS Trial Study Group. Effects of enalapril
on mortality in severe congestive heart failure: results of the
Cooperative North Scandinavian Enalapril Survival Study
(CONSENSUS). N Engl J Med 1987;316:1429-35.
6. PACKER M, POOLE-WILSON PA, ARMSTRONG PW et al.
Comparative effects of low and high doses of the angiotensinconverting enzyme inhibitor, lisinopril, on morbidity and mortality
in CHF. ATLAS Study Group. Circulation 1999;100:2312–2318.
7. PITT B, POOLE-WILSON PA, SEGAL R et al. Effect of losartan
compared with captopril on mortality in patients with
symptomatic heart failure: randomized trial—the Losartan Heart
Failure Survival Study ELITE II. Lancet 2000;355:1582–1587.
8. COHN JN, TOGNONI G. Arandomized trial of the angiotensinreceptor blocker valsartan in chronic heart failure. N Engl
J Med 2001;345:1667-75.
9. GRANGER CB, MCMURRAY JJ, YUSUF S, et al. Effects
of candesartan in patients with chronic heart failure and reduced
left-ventricular systolic function intolerant to angiotensinconverting-enzyme inhibitors: the CHARM-Alternative trial.
Lancet 2003;362:772-6.
10. VALIANT. N Engl J Med 2003;349:1893-906
11. MCMURRAY JJ, OSTERGREN J, SWEDBERG K et al. Effects
of candesartan in patients with CHF and reduced left-ventricular
systolic function taking angiotensin-converting-enzyme inhibitors:
the CHARM Added trial. Lancet 2003;362:767–771.
12. PACKER M, BRISTOW MR, COHN JN et al. The effect of
carvedilol on morbidity and mortality in patients with CHF. US
Carvedilol Heart Failure Study Group. N Engl J Med 1996;334:
1349–1355.
13. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a
randomized trial. Lancet 1999;353:9
14. (MERIT-HF). Effect of metoprolol CR/XL in CHF: Metoprolol
CR/XL Randomized Intervention Trial in Congestive Heart
Failure. Lancet 1999;353:2001–2007.
15. MARCUS D. FLATHER, MARCELO C. SHIBATA, ANDREW
J.S. COATS, DIRK J. VAN VELDHUISEN, et.al. Randomized
trial to determine the effect of nebivolol on mortality and
cardiovascular hospital admission in elderly patients with heart
failure (SENIORS) European Heart Journal (2005) 26, 215–225.
16. RONNIE WILLENHEIMER, DIRK J. VAN VELDHUISEN,
BERNARD SILKE, ERLAND ERDMANN, FERENC FOLLATH,
et al on behalf of the CIBIS III Investigators. Effect on Survival
and Hospitalization of Initiating Treatment for Chronic Heart
Failure With Bisoprolol Followed by Enalapril, as Compared
With the Opposite Sequence: Results of the Randomized
Cardiac Insufficiency Bisoprolol Study (CIBIS) III Circulation
2005 112: 2426-2435
17. PITT B, ZANNAD F, REMME WJ, et al, for the Randomized
Aldactone Evaluation Study Investigators. The effect of
spironolactone on morbidity and mortality in patients with severe
heart failure. N Engl J Med 1999;341:709-17.
18. PITT B, WILLIAMS G, REMME W, et al. The EPHESUS trial
eplerenone in patients with heart failure due to systolic
dysfunction complicating acute myocardial infarction: Eplerenone
Post- AMI Heart Failure Efficacy and Survival Study. Cardiovasc
Drugs Ther 2001;15:79-87.
19. The Digitalis Investigation Group. The effect of digoxin on
mortality and morbidity in patients with heart failure. N Engl
J Med 1997;336:525-33.
20. COHN JN, ARCHIBALD DG, ZIESCHE S, et al. Effect of
vasodilator therapy on mortality in chronic congestive heart
failure: results of a Veterans Administration Cooperative Study.
N Engl J Med 1986;314:1547-52.
21. LOEB HS, JOHNSON G, HENRICK A, et al, for the V-HeFT
VA Cooperative Studies Group. Effect of enalapril, hydralazine
plus isosorbide dinitrate, and prazosin on hospitalization
in patients with chronic congestive heart failure. Circulation
1993;87:
22. TAYLOR AL, ZIESCHE S, YANCY C et al. Combination of
isosorbide dinitrate and hydralazine in blacks with heart failure.
N Engl J Med 2004;351:2049–2057.
Tratamiento Pacientes en Estadio D.
1. ACC/AHA 2005 Guideline Update for the Diagnosis and
Management of Chronic Heart Failure in the Adult Circulation
2005:112;154-235
2. Guidelin es for the diagnosis and treatment of chronic heart
failure full text (update 2005) Swedberg et al. Eur Heart Journal.
h t t p : / / w w w. e s c a r d i o . o r g / k n o w l e d g e / g u i d e l i n e s /
Chronic_Heart_Failure.htm?escid=271120
3. STEVENSON L. Tailored therapy before transplantation for
treatment of advance heart failure: effective use of vasodilators
and diuretics. J heart lung transplant 91; 10:468
4. CRESPO M. Tratamiento de la insuficiencia cardiaca refractaria
o avanzada. Rev Esp Cardiol 2004; 57(9):869-83
5. The CONSENSUS Trial Study Group. Effects of enalapril on
mortality in severe congestive heart failure: results of the
Cooperative North Scandinavian Enalapril Survival Study
(CONSENSUS). N Engl J Med 1987;316:1429-35.
Revista Chilena de Cardiología - Vol. 26 Nº4, 2007
501